You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
PMPA (NMDA antagonist) is a short-chain competitive NMDA antagonist. PMPA (NMDA antagonist) displays Ki values of 0.84, 2.74, 3.53 and 4.16 μM at NMDAε1, NMDAε2 NMDAε3, and NMDAε4 subunit-containing receptors respectively.
1. Harris, N.C., et al. 1992. Brain Res. 594: 176-180. PMID: 1361408
2. Feng, B., et al. 2005. Neuropharmacology. 48: 354-359. PMID: 15721167
See how others have used PMPA (NMDA antagonist). Click on the entry to view the PubMed entry .
PMID: # 28301262 Nonnekens, J. et al. 2017. Cancer Biother. Radiopharm. 32: 67-73.
PMID: # 27446384 Zhang, Z. et al. 2016. Oncol Lett. 12: 1001-1006.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.